Supply Chain Intelligence

Olema Pharmaceuticals, Inc. Supply Chain

OLMA supply chain intelligence for Olema Pharmaceuticals, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

OLMA ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
0Customers
2Debt Items
20Related Chains

Olema Pharmaceuticals, Inc. Suppliers

TickerNameConfidenceEvidence
KR-OYSTER-POINT-II-LLC KR-OYSTER-POINT-II-LLC 92% The Company entered into a lease agreement with KR Oyster Point II, LLC, a Delaware limited liability company (the “Landlord”), pursuant to which the Company will lease an aggregate of approximately …
PFIZER-INC PFIZER-INC 92% Under the terms of the 2025 Pfizer Agreement, we are responsible for conducting the clinical trial for the combined therapies and Pfizer is responsible for supplying atirmociclib to us at no cost.
NOVARTIS-INSTITUTES-FOR-BIOMEDICAL-RESEARCH-INC NOVARTIS-INSTITUTES-FOR-BIOMEDICAL-RESEARCH-INC 90% The October 2023 Amendment No. 1 expanded the size of the ongoing ribociclib and palazestrant study cohort to a total of approximately 60 patients.
AURIGENE AURIGENE 80% Payments due to Aurigene upon or subsequent to regulatory approval will be accrued as a provision to cost of sales in the period when achievement of respective milestone target is probable

Olema Pharmaceuticals, Inc. Customers

No clients on recordNo downstream customers found in our database for Olema Pharmaceuticals, Inc..

Olema Pharmaceuticals, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
OLMA-DEBT Debt stack $4.0M 90% Market cache reports total debt of $4.0M.
OLMA-DEBT-11506 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.

Olema Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Olema Pharmaceuticals, Inc..

Olema Pharmaceuticals, Inc. Ownership

HolderNameConfidenceEvidence
OLMA-OWNER-JANUS-HENDERSON-GROUP-PLC JANUS HENDERSON GROUP PLC 90% 13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 202 tracked holders.

Olema Pharmaceuticals, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
COLL Collegium Pharmaceutical, Inc. 100.00 2
HLNCF Haleon plc 100.00 2
ELVN Enliven Therapeutics, Inc. 100.00 2
ABT Abbott Laboratories 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CPMV Mosaic ImmunoEngineering, Inc. 100.00 2
CCCC C4 Therapeutics, Inc. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
DEO Diageo plc 100.00 2
CHRS Coherus Oncology, Inc. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
SLGL Sol-Gel Technologies Ltd. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
CRBP Corbus Pharmaceuticals Holdings, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
DRTS Alpha Tau Medical Ltd. 100.00 2
View OLMA supply chain intel →

Explore the full interactive supply chain map for Olema Pharmaceuticals, Inc..

Open OLMA supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map